Validation of the Summit Lab Score in Predicting Exacerbations of Chronic Obstructive Pulmonary Disease Among Individuals with High Arterial Stiffness.

Benjamin D HorneRehan AliDawn Midwinter Catherine Scott-Wilson Courtney Crim Bruce E MillerDavid B Rubin

Published in: International journal of chronic obstructive pulmonary disease (2021)

The Summit Lab Score was associated with the 24-week risk of moderate-to-severe AECOPD in COPD patients with elevated CV risk. Secondarily, IMRS showed a trend towards differences in the risk of AECOPD, which was not statistically significant.

Keyphrases

chronic obstructive pulmonary disease
cystic fibrosis
blood pressure
early onset
high intensity
randomized controlled trial
clinical trial
study protocol